Clinical significance of pain in patients with chronic heart failure

被引:10
|
作者
Gan Qian
Zhang Feng-ru [2 ]
Zhou Qing-fen
Dai Li-ying
Liu Ye-hong
Chai Xi-chen
Wu Fang [2 ]
Shen Wei-feng [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Inst Cardiovasc Dis, Ruijin Hosp,Dept Cardiol, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Dept Geriatr, Ruijin Hosp, Shanghai 200025, Peoples R China
关键词
chronic heart failure; pain; quality of life; clinical outcome; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SYMPTOM; LIFE; HF;
D O I
10.3760/cma.j.issn.0366-6999.2012.18.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background There is a paucity of studies investigating the clinical and biochemical characteristics of pain in chronic heart failure (CHF) patients. This study aimed to determine the clinical and biochemical characteristics and outcomes in Chinese patients with CHF and symptoms of pain. Methods Sociodemographics, serum levels of creatinine, NT-proBNP, high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and two-dimensional echocardiographic left ventricular ejection fraction (LVEF) were determined in 305 patients with CHF. A questionnaire packet including the Brief Pain Inventory (BPI) and the Minnesota Living with Heart Failure Questionnaire (MLHFQ) was used to assess the degree of pain rated on a 0-10 scale and the quality of life (QOL). A six-minute walking test was performed during routine clinic visits. Major adverse cardiac events (MACE) were recorded; including all-cause or cardiac mortality and rehospitalization because of myocardial infarction, worsening heart failure or stroke at follow-up. Results Pain occurred in 25.6% of CHF patients, and was more common when the New York Heart Association (NYHA) functional class was worse. More patients with pain were female in gender, and had more co-morbidities, lower LVEF, and shorter distance during the 6-minute walking test. Despite similar serum levels of creatinine, N-terminal prohormone of brain natriuretic peptide (NT-proBNP), IL-6 and IL-10, the TNF-alpha levels were higher and MLHFQ scores were greater in CHF patients with pain. At follow-up, CHF patients with moderate to severe pain (>= 4 scale) had higher rates of all-cause and cardiac mortality and rehospitalization because of myocardial infarction, worsening heart failure or stroke. Multivariate regression analysis revealed that the presence of pain was an independent risk factor for MACE and reduced QOL in CHF patients. Conclusions Pain occurs in all stages of the CHF trajectory, and its incidence increases as clinical functional status is worsened. The presence of pain exerts a negative impact on clinical outcome and QOL in patients with CHF. Chin Med J 2012;125(18):3223-3227
引用
收藏
页码:3223 / 3227
页数:5
相关论文
共 50 条
  • [31] Clinical Significance of Endogenous Vasoactive Neurohormones in Chronic Systolic Heart Failure
    Tang, W. H. Wilson
    Shrestha, Kevin
    Martin, Maureen G.
    Borowski, Allen G.
    Jasper, Sue
    Yandle, Timothy G.
    Richards, A. Mark
    Klein, Allan L.
    Troughton, Richard W.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (08) : 635 - 640
  • [32] Do patients with chronic heart failure have chest pain?
    Clark, Andrew L.
    Goode, Kevin M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (01) : 185 - 189
  • [33] Clinical significance of rectus femoris diameter in heart failure patients
    Sato, Yoshimi
    Shiraishi, Hirokazu
    Nakanishi, Naohiko
    Zen, Kan
    Nakamura, Takeshi
    Yamano, Tetsuhiro
    Shirayama, Takeshi
    Matoba, Satoaki
    HEART AND VESSELS, 2020, 35 (05) : 672 - 680
  • [34] Clinical significance and prognostic value of anemia in heart failure patients
    Grzeslo, Agnieszka
    Jankowska, Ewa Anita
    Witkowski, Tomasz
    Petruk-Kowaiczyk, Jolanta
    Banasiak, Waldemar
    Ponikowski, Piotr
    KARDIOLOGIA POLSKA, 2007, 65 (02) : 184 - 191
  • [35] Clinical significance of rectus femoris diameter in heart failure patients
    Yoshimi Sato
    Hirokazu Shiraishi
    Naohiko Nakanishi
    Kan Zen
    Takeshi Nakamura
    Tetsuhiro Yamano
    Takeshi Shirayama
    Satoaki Matoba
    Heart and Vessels, 2020, 35 : 672 - 680
  • [36] The clinical significance of serum trimethylamine N-oxide (TMAO) level in patients with chronic heart failure
    An, Dongqi
    Zhan, Qiong
    Bai, Yujia
    Huang, Xingfu
    Lai, Wenyan
    Zeng, Qingchun
    Ren, Hao
    Xu, Dingli
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C144 - C145
  • [37] Clinical Significance of the Intensity of Pulmonary Second Heart Sound in patients with Heart Failure
    Iuchi, Kazuyuki
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (10) : S203 - S203
  • [38] CLINICAL SIGNIFICANCE OF AUTOANTIBODIES AGAINST CARDIAC TROPONIN I IN PATIENTS WITH MYOCARDIAL INFARCTION AND CHRONIC HEART FAILURE
    Yang Di
    Bian Zhiping
    Ji Peng
    Li Bing
    Chen Xiangjian
    Xu Jindan
    Gu Chunrong
    Zhang Jinan
    HEART, 2010, 96 : A211 - A212
  • [39] Clinical significance of 123I-BMIPP washout rate in patients with uncertain chronic heart failure
    Chihiro Aoshima
    Shinichiro Fujimoto
    Ayako Kudo
    Yuko O. Kawaguchi
    Kazuhisa Takamura
    Yuya Matsue
    Takao Kato
    Yoshifumi Kawamura
    Satoshi Kimura
    Yuki Kamo
    Yui O. Nozaki
    Daigo Takahashi
    Nobuo Tomizawa
    Makoto Hiki
    Takatoshi Kasai
    Shuko Nojiri
    Hideyuki Miyauchi
    Ken-ichi Hirano
    Kazunori Shimada
    Koji Murakami
    Tohru Minamino
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3129 - 3139
  • [40] Clinical significance of 123I-BMIPP washout rate in patients with uncertain chronic heart failure
    Aoshima, Chihiro
    Fujimoto, Shinichiro
    Kudo, Ayako
    Kawaguchi, Yuko O.
    Takamura, Kazuhisa
    Matsue, Yuya
    Kato, Takao
    Kawamura, Yoshifumi
    Kimura, Satoshi
    Kamo, Yuki
    Nozaki, Yui O.
    Takahashi, Daigo
    Tomizawa, Nobuo
    Hiki, Makoto
    Kasai, Takatoshi
    Nojiri, Shuko
    Miyauchi, Hideyuki
    Hirano, Ken-ichi
    Shimada, Kazunori
    Murakami, Koji
    Minamino, Tohru
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (09) : 3129 - 3139